Aus study - Perfect, price rises to ~40c
US study #1 - Total failure. Identified as issues with testing procedure not being strictly followed, price collapses to 6c.
US study #2 (current study) - Being monitored by ResApp to prevent total failure. If successful, should we not expect to see 30c+ again?
It all just sounds like a 'no brainer' to me, and I'm careful when I use that term especially on HC..
RAP Price at posting:
14.0¢ Sentiment: Hold Disclosure: Held
